Lenington Rachel's Insider Trades & SAST Disclosures
Lenington Rachel's most recent trade in Athira Pharma Inc was a trade of 10,000 Common Stock done . Disclosure was reported to the exchange on Sept. 3, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Lenington Rachel.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Athira Pharma Inc | Rachel Lenington | COO and CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 10,000 | 23,395 | - | 0 | Common Stock | |
| Athira Pharma Inc | Rachel Lenington | COO and CDO | Sale of securities on an exchange or to another person at price $ 0.57 per share. | 03 Sep 2024 | 2,525 | 20,870 | - | 0.6 | 1,429 | Common Stock |
| Athira Pharma Inc | Rachel Lenington | COO AND CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Athira Pharma Inc | Lenington Rachel | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 10,000 | 15,807 | - | 0 | Common Stock | |
| Athira Pharma Inc | Lenington Rachel | COO AND CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 10,000 | 15,807 | - | 0 | Common Stock | |
| Athira Pharma Inc | Rachel Lenington | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 2.91 per share. | 04 Jan 2024 | 2,412 | 13,395 | - | 2.9 | 7,019 | Common Stock |
| Athira Pharma Inc | Lenington Rachel | COO AND CDO | Sale of securities on an exchange or to another person at price $ 2.91 per share. | 04 Jan 2024 | 2,412 | 13,395 | - | 2.9 | 7,019 | Common Stock |
| Athira Pharma Inc | Rachel Lenington | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2023 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Athira Pharma Inc | Rachel Lenington | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges